<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-08-28T11:51:11Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/166867" metadataPrefix="mods">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/166867</identifier><datestamp>2025-11-06T16:51:51Z</datestamp><setSpec>com_10366_149436</setSpec><setSpec>com_10366_3947</setSpec><setSpec>com_10366_3946</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_151253</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Hernández García, Ángela Patricia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Rosales Fernández, Celia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Miranda Vera, Carolina</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Veselinova Marinova, Anzhela</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García Jambrina, Pablo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García-García, Pilar</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Díez Martín, David</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Castro González, María Ángeles</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Fuentes García, Manuel</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2025-09-01T07:10:20Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2025-09-01T07:10:20Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2024</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Hernández, Á., Rosales‐Fernández, C., Miranda‐Vera, C., Veselinova, A., Jambrina, P. G., García‐García, P., García, P. A., Díez, D., Castro, M. Á., y Fuentes, M. (2025). Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors. Archiv Der Pharmazie, 358(1), e2400600. https://doi.org/10.1002/ardp.202400600</mods:identifier>
<mods:identifier type="issn">0365-6233</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10366/166867</mods:identifier>
<mods:identifier type="doi">10.1002/ardp.202400600</mods:identifier>
<mods:identifier type="essn">1521-4184</mods:identifier>
<mods:abstract>[EN] Chemomodulation of natural cyclolignans as podophyllotoxin has been a successful&#xd;
approach to obtain semisynthetic bioactive derivates. One example of this approach is&#xd;
the FDA‐approved drug etoposide for solid and hematological tumors. It differs from&#xd;
the antimitotic activity of the natural product in its mechanism of action, this drug&#xd;
being a topoisomerase II inhibitor instead of a tubulin antimitotic. Within the&#xd;
molecular requirements for the activity of these compounds, the trans‐γ‐lactone&#xd;
moiety presented in the parent compound has always been a feature to be explored to&#xd;
chemomodulate its bioactivity. In this study, we have obtained different compounds&#xd;
that comply with the molecular characteristics for antitubulin and antitopoisomerase II&#xd;
activity combined in a single molecule. Furthermore, we explored the influence of the&#xd;
trans‐lactone moiety on the final activity, finding that the cis‐lactone was also interesting&#xd;
in terms of bioactivity. The best values of cytotoxicity and cell cycle inhibition&#xd;
were obtained for a compound lacking the lactone ring, thus mimicking the podophyllic&#xd;
aldehyde functionalization, a selective antimitotic podophyllotoxin derivate.&#xd;
The analogs with cis‐lactone also presented interesting cytotoxic activity. The present&#xd;
study illustrates the potential of the chemomodulation of natural products such as&#xd;
natural cyclolignan podophyllotoxin derivates for the discovery of new antitumor&#xd;
agents.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Cytotoxicity</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Dual-activity</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Molecular dynamics</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Natural products</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Podophyllic aldehyde</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin‐topoisomerase II inhibitors</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>